News on Velcade from BioPortfolio.com http://www.BioPortfolio.com Consolidated Velcade news from BioPortfolio.com Wed, 10 Feb 2010 06:54:25 GMT en TopoTarget Partner, Spectrum Pharmaceuticals, to host Conference Call Thursday 4 February 2010 at 19:00 CET (1http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018412&HITNO=0&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018412&THISHREF=http://c.moreover.com/click/here.pl%3fz2525657571%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018412&HITNO=0&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018412&THISHREF=http://c.moreover.com/click/here.pl%3fz2525657571%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: TopoTarget Partner, Spectrum Pharmaceuticals, to host Conference Call Thursday 4 February 2010 at 19:00 CET (1http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014950&HITNO=1&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014950&THISHREF=http://c.moreover.com/click/here.pl%3fz2524222295%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014950&HITNO=1&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014950&THISHREF=http://c.moreover.com/click/here.pl%3fz2524222295%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Bortezomib (Velcade) Starting Dose Adjustments for Patients With Hepatic Impairmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007909&HITNO=2&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007909&THISHREF=http://c.moreover.com/click/here.pl%3fz2521333950%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007909&HITNO=2&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007909&THISHREF=http://c.moreover.com/click/here.pl%3fz2521333950%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAAPS Pharmceutica: Research and Markets: Drive the Roadmap for Success in Oncology as Global Oncology Market is Projected to Outghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996883&HITNO=3&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996883&THISHREF=http://c.moreover.com/click/here.pl%3fz2516501196%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996883&HITNO=3&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996883&THISHREF=http://c.moreover.com/click/here.pl%3fz2516501196%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Velcade (bortezomib): Starting Dose Adjustments-Patients with moderate/severe Hepatic Impairment Should be Trehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988382&HITNO=4&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988382&THISHREF=http://c.moreover.com/click/here.pl%3fz2510973608%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988382&HITNO=4&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988382&THISHREF=http://c.moreover.com/click/here.pl%3fz2510973608%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDrugs.com: Revised Velcade Dosing for Patients with Hepatic Impairmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976586&HITNO=5&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976586&THISHREF=http://c.moreover.com/click/here.pl%3fz2504424054%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976586&HITNO=5&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976586&THISHREF=http://c.moreover.com/click/here.pl%3fz2504424054%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFacts & Comparisons: Millennium Pharma issues cancer-drug warninghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976630&HITNO=6&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976630&THISHREF=http://c.moreover.com/click/here.pl%3fz2504438846%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976630&HITNO=6&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976630&THISHREF=http://c.moreover.com/click/here.pl%3fz2504438846%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHouston Business Journal: Velcade (bortezomib): Starting Dose Adjustments-Patients with moderate/severe Hepatic Impairment Should be Trehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3969049&HITNO=7&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3969049&THISHREF=http://c.moreover.com/click/here.pl%3fz2500659166%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3969049&HITNO=7&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3969049&THISHREF=http://c.moreover.com/click/here.pl%3fz2500659166%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Health Canada approves first post-surgical treatment for patients with gastrointestinal stromal tumourshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968096&HITNO=8&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968096&THISHREF=http://c.moreover.com/click/here.pl%3fz2500149646%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968096&HITNO=8&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968096&THISHREF=http://c.moreover.com/click/here.pl%3fz2500149646%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Millennium issues cancer-drug warninghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968422&HITNO=9&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968422&THISHREF=http://c.moreover.com/click/here.pl%3fz2500366093%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968422&HITNO=9&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968422&THISHREF=http://c.moreover.com/click/here.pl%3fz2500366093%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBoston Business Journal: Millennium Pharma issues cancer-drug warninghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967402&HITNO=10&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967402&THISHREF=http://c.moreover.com/click/here.pl%3fz2499685725%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967402&HITNO=10&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967402&THISHREF=http://c.moreover.com/click/here.pl%3fz2499685725%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBoston Business Journal: J&J Beats, Guidance Disappointshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972478&HITNO=11&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972478&THISHREF=http://c.moreover.com/click/here.pl%3fz2502436193%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972478&HITNO=11&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972478&THISHREF=http://c.moreover.com/click/here.pl%3fz2502436193%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comI Stock Analyst: Velcade Prescribing Information Changedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971710&HITNO=12&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971710&THISHREF=http://c.moreover.com/click/here.pl%3fz2501987085%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971710&HITNO=12&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971710&THISHREF=http://c.moreover.com/click/here.pl%3fz2501987085%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comModern Medicine: Millennium Pharma issues cancer-drug warninghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3965854&HITNO=13&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3965854&THISHREF=http://c.moreover.com/click/here.pl%3fz2498747532%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3965854&HITNO=13&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3965854&THISHREF=http://c.moreover.com/click/here.pl%3fz2498747532%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Francisco Business Times: Millennium Pharma issues cancer-drug warninghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3965574&HITNO=14&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3965574&THISHREF=http://c.moreover.com/click/here.pl%3fz2498634021%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3965574&HITNO=14&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Velcade&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3965574&THISHREF=http://c.moreover.com/click/here.pl%3fz2498634021%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Journal of Jacksonville: